Anectine
These highlights do not include all the information needed to use ANECTINE safely and effectively. See full prescribing information for ANECTINE.ANECTINE (succinylcholine chloride) injection, for intravenous or intramuscular use Initial U.S. Approval: 1952
Approved
Approval ID
0b990f84-9515-44bd-a97d-a97bbead065c
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 29, 2023
Manufacturers
FDA
Civica, Inc.
DUNS: 081373942
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Succinylcholine Chloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code72572-750
Application NumberNDA008453
Product Classification
M
Marketing Category
C73594
G
Generic Name
Succinylcholine Chloride
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR, PARENTERAL
Effective DateJanuary 25, 2021
FDA Product Classification
INGREDIENTS (5)
SUCCINYLCHOLINE CHLORIDEActive
Quantity: 20 mg in 1 mL
Code: I9L0DDD30I
Classification: ACTIB
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
METHYLPARABENInactive
Quantity: 1 mg in 1 mL
Code: A2I8C7HI9T
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT